Related Experiment Videos

Therapy for small cell and non-small cell lung cancer

C P Belani¹, J Aisner

¹University of Maryland Cancer Center, Baltimore.

Current Opinion in Oncology

|April 1, 1990

Abstract

No abstract available in PubMed .

Related Concept Videos

Articles linked to this work by shared authors, journal, and citation graph.

A randomized trial of TLR-2 agonist CADI-05 targeting desmocollin-3 for advanced non-small-cell lung cancer.

Annals of oncology : official journal of the European Society for Medical Oncology·2016

A multicenter phase II study of cetuximab in combination with chest radiotherapy and consolidation chemotherapy in patients with stage III non-small cell lung cancer.

Lung cancer (Amsterdam, Netherlands)·2013

Identifying the target NSCLC patient for maintenance therapy: an analysis from a placebo-controlled, phase III trial of maintenance pemetrexed (H3E-MC-JMEN).

Annals of oncology : official journal of the European Society for Medical Oncology·2013

Phase Ib safety and pharmacokinetic study of volociximab, an anti-α5β1 integrin antibody, in combination with carboplatin and paclitaxel in advanced non-small-cell lung cancer.

Annals of oncology : official journal of the European Society for Medical Oncology·2012

Differential effect of age on survival in advanced NSCLC in women versus men: analysis of recent Eastern Cooperative Oncology Group (ECOG) studies, with and without bevacizumab.

Lung cancer (Amsterdam, Netherlands)·2012

Recent clinical developments and rationale for combining targeted agents in non-small cell lung cancer (NSCLC).

Cancer treatment reviews·2011

See all related articles